Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human (2) Apply Human filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Paediatric investigation plans Remove Paediatric investigation plans filter Orphan designations Remove Orphan designations filter Referrals Remove Referrals filter

Decision date

From:

To:

Date of opinion

From:

To:

Referral name

Referral status

European Commission final decision (2) Apply European Commission final decision filter

Referral type

Article 20 procedures Remove Article 20 procedures filter Article 31 referrals Remove Article 31 referrals filter

Referral reference number

Referral decision making model

PRAC-CAT-CHMP-EC (1) Apply PRAC-CAT-CHMP-EC filter PRAC-CHMP-EC (1) Apply PRAC-CHMP-EC filter

Referral authorisation model

Centrally and nationally authorised products (mixed) (1) Apply Centrally and nationally authorised products (mixed) filter Centrally authorised product(s) (1) Apply Centrally authorised product(s) filter

Referral PRAC recommendation

Risk minimisation measures Remove Risk minimisation measures filter Suspension Remove Suspension filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Medicine type

Conditional approval Remove Conditional approval filter Exceptional circumstances Remove Exceptional circumstances filter Orphan medicine Remove Orphan medicine filter Accelerated assessment (3) Apply Accelerated assessment filter Additional monitoring (12) Apply Additional monitoring filter Generic (1) Apply Generic filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

2 results

Remove all filtersRemove all filters

Medicine Orphan designations Remove Orphan designations filter Paediatric investigation plans Remove Paediatric investigation plans filter Referrals Remove Referrals filter

Medicine type Conditional approval Remove Conditional approval filter Exceptional circumstances Remove Exceptional circumstances filter Orphan medicine Remove Orphan medicine filter

Referral PRAC recommendation Risk minimisation measures Remove Risk minimisation measures filter Suspension Remove Suspension filter

Referral type Article 31 referrals Remove Article 31 referrals filter Article 20 procedures Remove Article 20 procedures filter

Sort by

List item

Referral: Zynteglo

betibeglogene autotemcel, associated names: Zynteglo, Article 20 procedures
Status: European Commission final decision, opinion/position date: 22/07/2021, EC decision date: 16/09/2021, Last updated: 08/07/2022
List item

Referral: Factor VIII

associated names: Iblias, Elocta, Kovaltry, Nuwiq, Obizur, NovoEight, Voncento, ReFacto AF, Kogenate Bayer, Helixate NexGen, Advate, Article 31 referrals
Status: European Commission final decision, opinion/position date: 14/09/2017, EC decision date: 10/10/2017, Last updated: 05/12/2017

2 results

Referral: Zynteglo

Referral: Factor VIII